16:11:05 EDT Fri 17 Jul 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Z:VATE - INNOVATE CORP - https://www.elev8hemp.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VATE - Z2.88.81·8.944.68.875-0.485-5.271.55719779.33  9.38  8.8521.295  3.7515:53:02Jul 0815 min RT 2¢

Recent Trades - Last 10 of 977
Time ETExPriceChangeVolume
15:53:10Z8.8653-0.48471
15:53:02Z8.815-0.5351
15:52:59Z8.8623-0.48771
15:52:50Z8.8569-0.493115
15:52:49Z8.815-0.5351
15:52:45Z8.82-0.5345
15:52:37Z8.8587-0.49138
15:52:35Z8.875-0.47510
15:52:29Z8.875-0.4755
15:52:27Z8.8624-0.48762

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-07-08 16:12U:VATENews ReleaseINNOVATE's Portfolio Company DBM Global to Pay Cash Dividend
2026-06-01 08:30U:VATENews ReleaseINNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting
2026-05-14 16:05U:VATENews ReleaseINNOVATE Corp. Announces First Quarter 2026 Results
2026-04-27 16:21U:VATENews ReleaseINNOVATE Corp. to Report First Quarter 2026 Results on May 14th
2026-04-06 08:30U:VATENews ReleaseINNOVATE's Portfolio Company DBM Global to Pay Cash Dividend
2026-04-03 14:34U:VATENews ReleaseDBM Global to Pay Cash Dividend
2026-03-31 08:05U:VATENews ReleaseMediBeacon(TM) Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation
2026-03-26 16:05U:VATENews ReleaseINNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results
2026-03-16 16:05U:VATENews ReleaseINNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th
2026-02-10 16:05U:VATENews ReleaseTransdermal GFR Article Recognized as One of Five 2025 Editors' Choice Articles by Journal of the American Society of Nephrology (JASN)
2026-02-02 08:30U:VATENews ReleaseINNOVATE's Portfolio Company DBM Global to Pay Cash Dividend
2026-01-30 16:05U:VATENews ReleaseDBM Global to Pay Cash Dividend
2025-12-16 08:05U:VATENews ReleaseMediBeacon(TM) Next Generation TGFR(TM) System Receives FDA Approval
2025-11-12 16:04U:VATENews ReleaseINNOVATE Corp. Announces Third Quarter 2025 Results
2025-10-22 16:06U:VATENews ReleaseINNOVATE Corp. to Report Third Quarter 2025 Results on November 12th
2025-10-21 08:05U:VATENews ReleaseMediBeacon receives regulatory approval to sell the Transdermal GFR System in China
2025-10-16 16:16U:VATENews ReleaseINNOVATE's Portfolio Company DBM Global to Pay Cash Dividend
2025-09-09 08:39U:VATENews ReleaseINNOVATE's Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial(TM) Skin Continuing to Redefine Aesthetic Innovation
2025-08-04 16:30U:VATENews ReleaseINNOVATE Closes Indebtedness Refinancing Transactions
2025-07-31 08:30U:VATENews ReleaseINNOVATE Announces Early Results of Exchange Offer of Senior Secured Notes and Solicitation of Consents and Extends Availability of Total Early Exchange Consideration